U.S. markets closed
  • S&P 500

    3,629.65
    -5.76 (-0.16%)
     
  • Dow 30

    29,872.47
    -173.77 (-0.58%)
     
  • Nasdaq

    12,094.40
    +57.62 (+0.48%)
     
  • Russell 2000

    1,845.02
    -8.51 (-0.46%)
     
  • Crude Oil

    45.00
    -0.71 (-1.55%)
     
  • Gold

    1,812.30
    +1.10 (+0.06%)
     
  • Silver

    23.31
    -0.14 (-0.60%)
     
  • EUR/USD

    1.1929
    +0.0016 (+0.13%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • GBP/USD

    1.3371
    +0.0015 (+0.11%)
     
  • USD/JPY

    103.9510
    -0.2990 (-0.29%)
     
  • BTC-USD

    17,189.02
    +22.37 (+0.13%)
     
  • CMC Crypto 200

    337.02
    -33.49 (-9.04%)
     
  • FTSE 100

    6,362.93
    -28.16 (-0.44%)
     
  • Nikkei 225

    26,618.26
    +80.95 (+0.31%)
     

Aquestive Therapeutics: 3Q Earnings Snapshot

·1 min read

WARREN, N.J. (AP) _ Aquestive Therapeutics Inc. (AQST) on Wednesday reported a loss of $16.6 million in its third quarter.

The Warren, New Jersey-based company said it had a loss of 49 cents per share.

The specialty pharmaceutical company posted revenue of $8.3 million in the period.

Aquestive Therapeutics expects full-year revenue in the range of $42 million to $46 million.

Aquestive Therapeutics shares have declined slightly more than 9% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $5.28, an increase of 24% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AQST at https://www.zacks.com/ap/AQST